High On‐Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)-Reference-Cited by-同舟云学术

High On‐Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)

Published:2012-05-03 Issue:3 Volume:1 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Pettersen Alf‐Åge R.¹²,Seljeflot Ingebjørg¹²³,Abdelnoor Michael⁴,Arnesen Harald¹²³

Affiliation:

1. From the Center for Clinical Heart Research, Oslo University Hospital, Ullevaal

2. Department of Cardiology, Oslo University Hospital, Ullevaal

3. and Faculty of Medicine, University of Oslo, Oslo, Norway

4. Section for Epidemiology and Statistics, Oslo University Hospital, Ullevaal

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection

2. Resistance to anti-platelet agents

3. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease

4. Current concepts about inhibition of platelet aggregation

5. Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. P2Y12 Receptor Inhibitor for Antiaggregant Therapies: From Molecular Pathway to Clinical Application;International Journal of Molecular Sciences;2024-07-10

2. Platelet reactivity in patients with coronary artery disease undergoing dual antiplatelet therapy with aspirin and clopidogrel;Biomedical Research and Therapy;2024-05-31

3. Antithrombotic Treatment for Chronic Coronary Syndrome: Evidence and Future Perspectives;Cardiology;2024-02-14

4. Do We Still Need Aspirin in Coronary Artery Disease?;Journal of Clinical Medicine;2023-12-06

5. Redefining the Roles of Aspirin across the Spectrum of Cardiovascular Disease Prevention;Current Cardiology Reviews;2023-11